Citi Sees Kadmon's Trials As 'Risky,' Initiates With Neutral Rating

By: via Benzinga
Citi has initiated coverage of Kadmon Holdings Inc (NYSE: KDMN) at Neutral, while its $12 price target represents a potential return of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.